Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design.

Liu, Xiaoyan; Kim, Chanmin; Han, Zifei; Lim, Pilar; Roychoudhury, Satrajit; Fava, Maurizio; Doros, Gheorghe

Liu, Xiaoyan; Kim, Chanmin; Han, Zifei; Lim, Pilar; Roychoudhury, Satrajit; Fava, Maurizio; Doros, Gheorghe.

Afiliación

Liu X; Department of Biostatistics, Boston University, Boston, Massachusetts, USA.
Kim C; Department of Biostatistics, Boston University, Boston, Massachusetts, USA.
Han Z; Department of Statistics, SungKyunKwan University, Seoul, Korea.
Lim P; School of Statistics, University of International Business and Economics, Beijing, China.
Roychoudhury S; Janssen Research & Development LLC, Raritan, New Jersey, USA.
Fava M; Pfizer Inc., New York, New York, USA.
Doros G; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Stat Med ; 41(12): 2166-2190, 2022 05 30.

Article en En | MEDLINE | ID: mdl-35184326

Asunto(s)

Efecto Placebo; Proyectos de Investigación; Sesgo; Simulación por Computador; Humanos

Palabras clave

SPCD; estimand; placebo response; principal stratification; treatment effect

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proyectos de Investigación / Efecto Placebo Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Stat Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google